Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2023-05-05
2043-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Screening of Gestational Diabetes Mellitus and Prospective Cohort Study of Postpartum Follow-up
NCT03825926
The Study of Biomarker in Early Diagnosis of GDM by Metabolomics
NCT05733195
Biomarkers for Early Screening of Gestational Diabetes Mellitus
NCT05142020
Shanghai Clinical Cohort of Hyperglycemia in Pregnancy
NCT07161947
"Mantou" Screening for GDM Before 20 Weeks of Gestation
NCT06436794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old
* Signed the informed consent form to voluntarily enroll in the management follow-up
Exclusion Criteria
* Pregnant women with severe organic diseases or mental illnesses
* Any condition deemed by the investigator to affect eligibility for the study
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai General Hospital, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yufan Wang
Chief Physician, Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai General Hospital, China
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022SQ506
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.